137 related articles for article (PubMed ID: 29484186)
21. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.
Thomsen IP; Sapparapu G; James DBA; Cassat JE; Nagarsheth M; Kose N; Putnam N; Boguslawski KM; Jones LS; Wood JB; Creech CB; Torres VJ; Crowe JE
J Infect Dis; 2017 Apr; 215(7):1124-1131. PubMed ID: 28186295
[TBL] [Abstract][Full Text] [Related]
23. Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps.
Laudien M; Gadola SD; Podschun R; Hedderich J; Paulsen J; Reinhold-Keller E; Csernok E; Ambrosch P; Hellmich B; Moosig F; Gross WL; Sahly H; Lamprecht P
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):51-5. PubMed ID: 20412703
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus α-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children.
Yu KO; Randolph AG; Agan AA; Yip WK; Truemper EJ; Weiss SL; Ackerman KG; Schwarz AJ; Giuliano JS; Hall MW; Bubeck Wardenburg J; ;
J Infect Dis; 2016 Dec; 214(11):1638-1646. PubMed ID: 27651418
[TBL] [Abstract][Full Text] [Related]
25. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial.
François B; Mercier E; Gonzalez C; Asehnoune K; Nseir S; Fiancette M; Desachy A; Plantefève G; Meziani F; de Lame PA; Laterre PF;
Intensive Care Med; 2018 Nov; 44(11):1787-1796. PubMed ID: 30343314
[TBL] [Abstract][Full Text] [Related]
26. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
[TBL] [Abstract][Full Text] [Related]
27. Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.
Conti F; Ceccarelli F; Iaiani G; Perricone C; Giordano A; Amori L; Miranda F; Massaro L; Pacucci VA; Truglia S; Girelli G; Fakeri A; Taliani G; Temperoni C; Spinelli FR; Alessandri C; Valesini G
Arthritis Res Ther; 2016 Jul; 18():177. PubMed ID: 27475749
[TBL] [Abstract][Full Text] [Related]
28. Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Jankovic J; Goodman I; Safirstein B; Marmon TK; Schenk DB; Koller M; Zago W; Ness DK; Griffith SG; Grundman M; Soto J; Ostrowitzki S; Boess FG; Martin-Facklam M; Quinn JF; Isaacson SH; Omidvar O; Ellenbogen A; Kinney GG
JAMA Neurol; 2018 Oct; 75(10):1206-1214. PubMed ID: 29913017
[TBL] [Abstract][Full Text] [Related]
29. Synergism of Staphylococcus aureus colonization and allergic reaction in the nasal cavity in mice.
Hohchi N; Hashida K; Ohkubo J; Wakasugi T; Mori T; Nguyen KH; Kuroda E; Ikeno T; Taniguchi H; Suzuki H
Int Arch Allergy Immunol; 2012; 159(1):33-40. PubMed ID: 22555155
[TBL] [Abstract][Full Text] [Related]
30. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model.
Smith HL; Cheslock P; Leney M; Barton B; Molrine DC
Virulence; 2016 Aug; 7(6):660-8. PubMed ID: 27070129
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
32. Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.
Worlitzsch D; Kaygin H; Steinhuber A; Dalhoff A; Botzenhart K; Döring G
Antimicrob Agents Chemother; 2001 Jan; 45(1):196-202. PubMed ID: 11120965
[TBL] [Abstract][Full Text] [Related]
33. Frequency of superantigen encoding genes of Staphylococcus aureus isolates collected from multiple sclerosis (MS) patients and nasal carriers.
Sadeghi J; Alizadeh N; Ahangar Oskouei M; Laghusi D; Savadi Oskouei D; Nikanfar M; Seyyed Mousavi MN
Microb Pathog; 2019 Feb; 127():316-319. PubMed ID: 30553909
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis.
Caballero AR; Foletti DL; Bierdeman MA; Tang A; Arana AM; Hasa-Moreno A; Sangalang ERB; O'Callaghan RJ
Ocul Immunol Inflamm; 2015 Aug; 23(4):297-303. PubMed ID: 24912088
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.
Ortines RV; Liu H; Cheng LI; Cohen TS; Lawlor H; Gami A; Wang Y; Dillen CA; Archer NK; Miller RJ; Ashbaugh AG; Pinsker BL; Marchitto MC; Tkaczyk C; Stover CK; Sellman BR; Miller LS
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311091
[No Abstract] [Full Text] [Related]
36. Use of enzyme-linked immunosorbent assay to measure bovine milk and serum antibodies to alpha toxin, beta toxin, and capsular antigens of Staphylococcus aureus.
Loeffler DA; Norcross NL
Vet Immunol Immunopathol; 1987 Feb; 14(2):145-56. PubMed ID: 3564362
[TBL] [Abstract][Full Text] [Related]
37. Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adults.
Slow S; Priest PC; Chambers ST; Stewart AW; Jennings LC; Florkowski CM; Livesey JH; Camargo CA; Scragg R; Murdoch DR
Clin Microbiol Infect; 2014 May; 20(5):453-8. PubMed ID: 24004292
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.
Hawthorne T; Giot L; Blake L; Kuang B; Gerwien R; Smithson G; Hahne W; Mansfield T; Starling GC; Pochart P; Hoelscher D; Halvorsen YD
Int J Clin Pharmacol Ther; 2008 May; 46(5):236-44. PubMed ID: 18538109
[TBL] [Abstract][Full Text] [Related]
39. Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against
Deng R; Zhou C; Li D; Cai H; Sukumaran S; Carrasco-Triguero M; Saad O; Nazzal D; Lowe C; Ramanujan S; Kamath AV
MAbs; 2019; 11(6):1162-1174. PubMed ID: 31219754
[TBL] [Abstract][Full Text] [Related]
40. A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
Sheldon E; Kitchin N; Peng Y; Eiden J; Gruber W; Johnson E; Jansen KU; Pride MW; Pedneault L
Vaccine; 2016 Apr; 34(18):2082-91. PubMed ID: 26993331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
